CDH1 and dysplasia: Seventy-five percent (75%) of severe dysplasia cases and 53% of mild dysplasia cases expressed mild and moderate E-cadherin intensity, respectively. In this study, 58% of well-differentiated OSCC cases expressed moderate intensity of E-cadherin but 82% of moderately differentiated OSCC cases expressed mild intensity (Table 2) (Figures 5, 6).